You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 18, 2025

Details for New Drug Application (NDA): 081002

✉ Email this page to a colleague

« Back to Dashboard

NDA 081002 describes MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE, which is a drug marketed by Hospira, Icu Medical Inc, Intl Medication, Specgx Llc, Watson Labs, and West-ward Pharms Int, and is included in six NDAs. Additional details are available on the MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE profile page.

The generic ingredient in MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE is meperidine hydrochloride. There are six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the meperidine hydrochloride profile page.

Summary for 081002

Tradename:	MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE
Applicant:	West-ward Pharms Int
Ingredient:	meperidine hydrochloride
Patents:	0

Medical Subject Heading (MeSH) Categories for 081002

Adjuvants, Anesthesia
Analgesics, Opioid
Narcotics

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	10MG/ML
Approval Date:	Jul 30, 1993	TE:		RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.